|
| Time/Date | Code | Headline | Source | Impact |
|---|---|---|---|---|
| 07:00 26-Mar-2013 | AZN | Filing of Annual Report on Form 20-F with SEC | RNS | +3.50% |
| 11:38 25-Mar-2013 | AZN | Annual Financial Report | RNS | +3.88% |
| 07:00 25-Mar-2013 | AZN | AstraZeneca settles over Crestor patent | RNS | +3.88% |
| 07:00 21-Mar-2013 | AZN | AstraZeneca announces agreement with Moderna | RNS | +6.12% |
| 07:00 21-Mar-2013 | AZN | AstraZeneca partners Karolinska Institute | RNS | +6.12% |
| 07:00 21-Mar-2013 | AZN | AstraZeneca outlines growth strategy | RNS | +6.12% |
| 13:00 18-Mar-2013 | AZN | AstraZeneca to establish strategic R&D centres | RNS | +2.62% |
| 10:00 14-Mar-2013 | AZN | Block Listing Application | RNS | +0.44% |
| 07:00 05-Mar-2013 | AZN | Australian court holds crestor patents invalid | RNS | +1.09% |
| 16:00 01-Mar-2013 | AZN | Total Voting Rights | RNS | +1.54% |
| 10:00 27-Feb-2013 | AZN | Director/PDMR Shareholding | RNS | +2.11% |
| 10:00 27-Feb-2013 | AZN | Director/PDMR Shareholding | RNS | +2.11% |
| 10:00 27-Feb-2013 | AZN | Director/PDMR Shareholding | RNS | +2.11% |
| 10:00 27-Feb-2013 | AZN | Director/PDMR Shareholding | RNS | +2.11% |
| 16:00 01-Feb-2013 | AZN | Total Voting Rights | RNS | -2.54% |
| 07:00 31-Jan-2013 | AZN | Final Results | RNS | -2.65% |
| 07:00 31-Jan-2013 | AZN | Final Results | RNS | -2.65% |
| 09:00 30-Jan-2013 | AZN | Notice of Results | RNS | -2.96% |
| 13:00 15-Jan-2013 | AZN | Announces changes to Senior Executive Team | RNS | +1.69% |
| 16:00 02-Jan-2013 | AZN | Total Voting Rights | RNS | +2.06% |
The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.
By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.
You will be redirected in five seconds.
You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.
The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.
By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.
You will be redirected in five seconds